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cognitive impairment. We have explored the effects of acute Al citrate intoxication on both
hippocampal morphology and mnemonic processes in rodents. Adult male Wistar rats were
intoxicated with a daily dose of Al citrate (320mg/kg) during 4 days by gavage. Animals were
perfused at 8 (G2), 17 (G3) and 31 days (G4) after intoxication. Control animals were treated with
sodium citrate (G1). Animals were submitted to behavioral tests of open field and elevated
T-maze. Immunohistochemistry was performed to label neurons (anti-NeuN) and astrocytes
(anti-GFAP) in both CA1 and CA3 hippocampal regions. There was an increase in the locomotor
activity in open field test for G2 in comparison to control group and other groups (ANOVA-
Bonferroni, Po0.05). The elevated T-maze avoidance latency (AL) was higher in all intoxicated
groups compared to control (Po0.05) in avoidance 1. These values remained elevated in
avoidance 2 (Po0.05), but abruptly decreased in G2 and G3, but not in G1 and G4 animals in
avoidance 3 (Po0.05). There were no significant differences for 1 and 2 escape latencies. There
were intense neuronal loss and a progressive decrease in GFAP immunoreactivity in the
hippocampus of intoxicated animals. The results suggest that Al citrate treatment induces
deficits on learning and memory concomitant with neuronal loss and astrocyte impairment in
the hippocampus of intoxicated rats.
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Aluminum (Al) is ubiquitously distributed over the earth
crust and is widely used in natural processes and human
activities (Nayak, 2002). This metal is present in higher
amounts in soil surrounding waste sites from coal industries,
mining and Al smelting (Jackson and Huang, 1983). Al con-
centration in the soil is frequently increased by acid rain,
which can contribute to environmental problems and food
contamination (Jackson and Huang, 1983; Nayak, 2002). Al
has access to the body through dietary, iatrogenic and
occupational exposures (Nayak, 2002; Walton, 2007). Al can
be absorbed by plant roots grown in acid soils and is also
present in several food additives (Walton, 2007). About 20% of
Al human intake occur from using Al-maiden food utensils,
including pans, pots, kettles, and trays (Lione, 1983). It has
been shown that Al intake through the diet route is about
7–10 mg/day for adult humans (Flarend et al., 2001). Al is a
contaminant of some intravenous solutions used in some
medical conditions and in medications, including antacids,
buffered aspirins, antidiarrheal products, douches and
hemorroidal (Alfrey, 1993; Klein, 2005; Lione, 1985; Poole
et al., 2008). Finally, Al contamination may occur by occupa-
tional exposure, mainly workers of Al refining, metal indus-
tries and automotive dealerships (Bjor et al., 2008; Sinczuk-
Walczak et al., 2003, 2005).
Regardless the contamination source, Al can have access to
the body via inhalation and absorption by the olfactory system
or lung epithelia and gastrointestinal tract in the case of Al
swallowing (Exley et al., 1996; Walton, 2007). From the blood
stream, Al can accumulate in different tissues, including brain,
bone, kidneys, muscle, and heart (Anthony et al., 1986; Nayak,
2002). Brain is a preferential site of Al accumulation in both gray
and white matter, mainly at some cortical regions and hippo-
campus (Kawahara, 2005; Miu et al., 2003; Walton, 2009).
Al is a highly neurotoxic compound at higher concen-
trations. Neurotoxic actions of this metal induce clinical
symptoms in humans, including memory loss, tremor, jerking
movements, impaired coordination, and sluggish motor
movement, loss of curiosity, ataxia, myoclonic jerks, and
generalized convulsions with status epilepticus (Buchta et al.,
2003; Kiesswetter et al., 2009). These symptoms are related to
several pathological conditions, such as Alzheimer’s disease,
Down syndrome with manifested Alzheimer’s disease, amyo-
trophic lateral sclerosis, Parkinsonian dementia, dialysis ence-
phalopathy and alcohol dementia (Ribes et al., 2010; Shaw and
Petrik, 2009; Tomljenovic, 2011).
There is experimental evidence in vitro (Rui and Yongjian,
2010; Zhang et al., 2008) and in vivo (Fattoretti et al., 2004;
Sreekumaran et al., 2003; Walton, 2009) suggesting that the
hippocampus is damaged following Al intoxication. Al chloride
induced oxidative damage on cells derived from hippocampus
and cortex of mice (Rui and Yongjian, 2010). In vivo, chronic Al
intoxication induces cortical and hippocampal damage with
alterations in both axons and dendritic branches (Fattoretti
et al., 2004; Sreekumaran et al., 2003; Walton, 2009). In addition
to neuronal damage, Al intoxication may affect glial cells, mainly
astrocytes (Guo-Ross et al., 1999; Nedzvetsky et al., 2006; Struys-
Ponsar et al., 2000).Some studies have suggested chronic Al intoxication may
induce behavioral deficits, including learning and memory
impairments (Ribes et al., 2010; Xiao et al., 2011). In these
studies, mainly chronic intoxication protocols were used and
behavioral tests were not normally associated with morpho-
logical techniques to address neuronal loss and glial reactiv-
ity (Sethi et al., 2008; Xiao et al., 2011). Although chronic
intoxications are closer to the situation in which humans are
contaminated in the polluted environment, it has been
shown that acute Al intoxication causes encephalopathy in
humans (Perazella and Brown, 1993; Berend et al., 2001) and
neuropathological changes (Forrester and Yokel, 1985; Kumar,
1998) as well as damage to other organs (El-Sayed et al., 2011)
in experimental animals.
In this study, we investigated the effects of aluminum
intoxication on hippocampal neurons and astrocytes as well
as in learning and memory performances in different survival
times following acute intoxication of adult rats with Al
citrate.2. Results
2.1. Acute aluminum-citrate intoxication increases the
walking distance in the open field test
There was no conspicuous body weight loss in most of the
animals treated with Al citrate in relation to control animals.
Animal death was rarely present in all investigated groups
(less than 1%). Nevertheless, Al citrate treatment induced
increased (Po0.05, ANOVA-Bonferroni,) locomotor activity
(increased walking distance) in Group 2 animals compared
to control (G1) and other intoxicated groups (G3 and G4)
(Fig. 1). There was no statistical difference between G3 and G4
compared to G1 (P40.05). In addition, there were no differ-
ences (P40.05) between groups for the other open field
parameters (rearing, grooming and freezing) (Fig. 1).
2.2. Aluminum-citrate intoxication induces learning and
memory deficits in the elevated T-maze test
Two behavioral parameters were evaluated using the elevated
T-maze test: inhibitory avoidance latency (IAL) and scape
latency (SL). The IAL was significantly higher in intoxicated
animals compared to control (Fig. 2A, Po0.05, Friedman test
for repeated measures). The total averages were 29.96, 103.52,
156.75 and 75.06 s in the four attempts for baseline, avoi-
dances 1, 2 and 3, respectively (w2 (3, N¼29)¼17.43, Po0.05).
As illustrated in Fig. 2, the rat permanence time in the closed
arm significantly increased from the baseline up to avoidance
2. From avoidance 3 (memory test), there was a significant
decrease (Po0.05) in this behavioral parameter in all intoxi-
cated, but not in the control group (P40.05), characterizing a
learning deficit (Fig. 2).
The IALs were compared between groups using ANOVA.
The results are illustrated in Fig. 2B. Thirty seconds after the
baseline test, animals were submitted to avoidance 1 test.
Animals from all experimental groups presented a higher
IAL, compared to baseline (Po0.05), but there were no
differences between intoxicated groups (P40.05, Fig. 2B).
Fig. 1 – Open field results following Al citrate intoxication. Average response for control animals (G1) and animals intoxicated
with a single dose of Al citrate (320 mg/Kg) and perfused at 8 days (G2), 17 days (G3) and 31 days (G4). The open field
parameter walking distance (A), rearing (B), grooming (C) and freezing (D) were evaluated in the test. There was an increase
in the walking distance in G2 animals, compared to G1 (Po0.05, ANOVA-Bonferroni) and G3 and G4 (þPo0.05).
Fig. 2 – Elevated-T maze results following Al citrate intoxication. Average of avoidance latency response for G1, G2, G3 and G4
animals. Differences between groups for all avoidance attempts (A) and comparative analysis of avoidance attempts inside
each experimental group (B).Statistically significant comparisons with baseline (Po0.05) or avoidance 3 (þPo0.05).
Intoxicated animals presented differences on avoidance latencies compared to baseline and control group, suggesting
Al-induced learning and memory deficits.
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 2 3 – 3 3 25
b r a i n r e s e a r c h 1 4 9 1 ( 2 0 1 3 ) 2 3 – 3 326For the avoidance 2 test, there were statistical differences
between groups. There was a reduction in the IAL for animals
belonging to G2 (98.57 s), G3 (168.00 s) and G4 (146.87 s),
compared to G1 (300.00 s) (Po0.05, Fig. 2B).
The avoidance 3 test (memory test) was performed at 3 days
after avoidance 2 test. There was a statistically significant
decrease in the IAL for G2 and G3, compared to G1 (Po0.05,
Fig. 2A), which suggests a learning deficit. Animals belonging to
G4 did not present a significant IAL decrease (P40.05).
Fig. 2B illustrates a comparative analysis for all avoidances
in each experimental group. G1 animals presented a signifi-
cant IAL increase for avoidances 1, 2 and 3 (Po0.05), com-
pared to baseline. G2 animals remained a longer time in the
closed arm in avoidance 1, while a significant reduction of
IAL was observed in avoidances 2 and 3 (Po0.05), character-
izing a memory deficit. G3 animals presented increased IALs
in avoidances 1 and 2, while a decreased IAL was observed for
avoidance 3, compared to previous attempts (Po0.05). Finally,
G4 animals did not present significant statistical differences
between avoidances (Fig. 2B, P40.05).Fig. 3 – Hippocampal Neuronal damage following Al citrate int
and CA3 hippocampal areas for animals belonging to G1 (A)–(C),
present normal morphology (A)–(C), but morphological alteratio
immunoreactivity were observed in the intoxicated animals (G2
G, J. Scale bars: A, D, G, J (300 lm); B–F, H–I, L–M (100 lm).The analysis of SL parameter in the open arm of the
elevated T-maze did not show any statistical differences
between groups (data not shown).
2.3. Aluminum-citrate treatment induces neuronal loss
in the hippocampus of adult rats
To evaluate the effect of Al citrate treatment on neuronal
density in CA1 and CA3 hippocampal regions, we performed
immunohistochemistry against NeuN specific neuronal
marker (Mullen et al., 1992). Al citrate treatment resulted in
conspicuous neuronal loss in both CA1 and CA3 from G2, G3
and G4 animals, compared to G1 (Fig. 3). These results were
confirmed by quantitative analysis (Fig. 4). There was a
decrease in the numbers of NeuNþ cells per field in both
CA1 and CA3 of G2, G3 and G4 animals, compared to G1
(Fig. 4, Po0.05).Comparisons between G2, G3 and G4 were no
statistically significant (P40.05).
Aluminum-citrate intoxication induces a progressive
decrease in the hippocampal GFAP reactivity.oxication. Immunohistochemistry against NeuN in the CA1
G2 (D)–(F), G3 (G)–(I) and G4 (J)–(M). In G1, CA1 and CA3 areas
ns, including cell loss, layer thinning and decreased NeuN
, G3 and G4). B–C, E–F, H–I, L–M are magnified images of A, D,
Fig. 4 – Quantitative analysis of neuronal loss following Al
citrate intoxication. Average (7SE) of NeuN immunopositive
cells/field in both control (G1) and intoxicated animals (G2,
G3 and G4). There was a decrease in the number of NeuNþ
cells/field in intoxicated animals compared to control
(Po0.05, ANOVA-Bonferroni) in both CA1 (A) and CA3
(B) hippocampal regions. SE¼standard error.
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hippocampal astrocytes, we performed immunohistochemi-
stry against GFAP—a classical astrocyte marker (Gomes-Leal
et al., 2004).There was a progressive decrease on GFAP
reactivity in animals belonging to G2, G3 and G4, compared
to G1 (Fig. 5). The loss of GFAP reactivity was more intense in
G3 (Fig. 5E and F) and G4 (Fig. 5G and H) animals, but
preferentially in the last experimental group.3. Discussion
In this study, we have investigated the behavioral and
neuropathological effects of the acute experimental intoxi-
cation of adult rats with Al citrate. Intoxicated animals
presented learning and memory deficits as well as hippo-
campal neuronal loss and astrocytic impairment, compared
to control animals.
We have used Al citrated as intoxicant. This Al compound
is suitable for experimental Al intoxication, considering that
it allows a better Al solubility and gastrointestinal absorptioncompared to other Al compounds (Arnich et al., 2004;
Domingo et al., 1988; Kumar, 1998). It follows that the choice
of Al citrate in this study certainly allowed a better Al
penetration through the blood brain barrier and deposition
in the CNS (Arnich et al., 2004; Domingo et al., 1988).
One can argue against the lack of SC-intoxicated in the
same time period of G3 and G4 animals. SC is an innocuous
substance to the CNS. This has been noted in both G1 and G2
groups. In an ongoing investigation animals injected with
sodium citrate and perfused at 28 days following Al citrate
injection did not present any histological or behavioral sign
of pathological impairment (data not shown).
Al citrated intoxication induced an increase the walking
distance, but not in the other parameters of the open field
test. Other studies using different Al compounds reported
similar results, in which Al-intoxicated animals did not
present locomotor alterations for several open field test
parameters (Domingo et al., 1996; Ribes et al., 2008; Sethi
et al., 2008). Ribes et al. (2008) reported increased open field
walking distances in transgenic mice intoxicated with Al
lactate. Similar results were described by Sethi et al., 2008
using Al chloride. In this study by Seth and colleagues,
hyperexcitability was confirmed by both behavioral tests
and electrophysiological analysis. This is likely due to
increased anxiety related to the acute phase of Al intoxica-
tion. It has been reported that Al intoxication alters some
emotional aspects of animal behavior, which is reflected in
higher open field scores (Miu et al., 2003).
Al-intoxicated animals presented differences on the IAL
compared to non-intoxicated animals. This can be inter-
preted as a memory-learning deficit induced by the Al
intoxication. Similar results have been described in previous
investigations using other Al compounds (Sethi et al., 2008;
Struys-Ponsar et al., 1997). Peripheral administration of Al
chloride caused learning and memory deficits (Sethi et al.,
2008; Struys-Ponsar et al., 1997).
We have observed that G4 animals had a higher perma-
nence time in the closed arm of the elevated-T maze in the
avoidance 1, compared to baseline and control group. It has
been shown that the animal latency time is normally shorter
in the closed arm for avoidance 1 than in the subsequent
attempts, considering that in this first test animals normally
explore more the open arms, compared the closed ones
(Graeff et al., 1998; Viana et al., 1994). It is likely that the
longer permanence of the animals in the closed arms of the
elevated-T maze was a pathological consequence of the Al-
citrate intoxication.
In avoidance 2, animals belonging to all intoxicated groups
decreased the permanence time in the closed arms. This
finding suggests an effect of Al intoxication on the short term
memory. In avoidance 3, which is performed at 72 h after
avoidance 2, intoxicated animals presented a reduced per-
manence time in the closed arms compared to control group,
which suggests deficits on the long term memory. It is known
that the long term memory is consolidated in some hours
and can be recovered in days or months after the aversive
stimulus (Antonov et al., 2010; Izquierdo and Medina, 1997;
Izquierdo et al., 1999). Considering that intoxicated animals
had difficulties on the avoidance learning, it is likely that Al
caused impairment in the learning consolidation of the
Fig. 5 – Decreased GFAP immunoreactivity following Al citrate intoxication. Immunohistochemistry against GFAP in the CA1
and CA3 hippocampal areas for animals belonging to G1 (A)–(B), G2 (C)–(D), G3 (E)–(F) and G4 (G)–(H). In G1, GFAPþastrocytes
present a normal morphology and pattern of immunoreactivity (A)–(B). A considerable decrease of GFAP immunoreactivity
was observed in the intoxicated animals. B, D, F, H are magnified images of A, C, E, G. A, C, E, G (300 lm); B, D, F, H (300 lm).
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memory deficit.
Other studies have reported learning and memory deficits
following intoxication with Al and other heavy metals, including
methylmercury (Carobrez and Bertoglio, 2005; Kaneko et al.,
2006; Maia et al., 2009; Ribes et al., 2010; Xiao et al., 2011).
In these studies, animals contaminated with ethanol andmethylmercury presented learning impairment, characterized
by reduced permanence time in the closed arms of the elevated-
Tmaze in the first avoidance response, characterizing short term
memory deficits (Carobrez and Bertoglio, 2005; Maia et al., 2009).
This has also been observed in avoidance 3, performed more
than 24 h after avoidance 1, characterizing long term memory
deficits (Carobrez and Bertoglio, 2005; Maia et al., 2009).
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damage induced by Al citrate on CNS regions important for
learning and memory. We have investigated this possibility
by assessing neuronal density and GFAP immunoreactivity in
both CA1 and CA3 hippocampal regions. Decreased densities
of CA1 and CA3 neurons as well as progressive decrease on
GFAP immunoreactivity were observed in Al-intoxicated ani-
mals. These findings are supported by previous studies
in vitro and in vivo showing hippocampal damage following
Al intoxication (El-Rahman, 2003; Levesque et al., 2000;
Meshitsuka and Aremu, 2008; Sethi et al., 2008).
Chronic intoxication with aluminum sulfate induces dis-
organization of the pyramidal hippocampal layer, neuronal
loss and neurofibrillary degeneration in adult rats (El-
Rahman, 2003; Sethi et al., 2008). Other CNS areas are affected
by Al intoxication, including neocortex, olfactory bulb,
hypothalamus, striatum and cerebellum, although the hip-
pocampus is preferentially affected (Struys-Ponsar et al.,
1994; Sumathi et al., 2011).
The neurotoxic effects of Al compounds are related to a
preferential tropism of this metal for CNS structures (Oteiza
et al., 1993; Zatta et al., 1993). In the CNS, Al can interfere
with several physiological processes, inducing damage by
oxidative stress, membrane biophysics alterations, deregula-
tion of cell signaling, and impairment of neurotransmission
(Pohl et al., 2011; Verstraeten et al., 2008).
The Al citrate intoxication induced a progressive decrease
on GFAP immunoreactivity. Previous studies reported that Al
intoxication interferes with astrocyte function (Erazi et al.,
2010). Nevertheless, the Al effect on astrocyte population is
variable depending on the experimental model. Some reports
suggest that Al intoxication may decrease astrocyte function
(Guo-Ross et al., 1999; Struys-Ponsar et al., 2000; Suarez-
Fernandez et al., 1999), while other suggest the opposite
(Nedzvetsky et al., 2006; Yokel and O’Callaghan, 1998;Sethi
et al., 2008). In this study, it was clear that Al citrate
intoxication induces astrocyte damage. The impairment
in astrocyte function may contribute to neuronal damage.
In vitro studies suggest that astrocyte damage contribute
to neuronal loss (Aremu and Meshitsuka, 2005; Meshitsuka
and Aremu, 2008; Sass et al., 1993). It has been suggested that
Al treatment impair astrocytes to protect neurons from
glutamate-induced excitotoxicity (Sass et al., 1993). The
progressive accumulation of Al in astrocytes may protect
neurons in early times after intoxication. Nevertheless, the
pathological accumulation of Al may damage astrocytes in
later time points. This is in agreement with the described loss
of GFAP immunoreactivity in later survival times following Al
intoxication.
An apparent drawback of our study is the lack of quanti-
tative analysis for GFAP immunoreactivity. Nevertheless,
changes in GFAP immunoreactivity can be qualitatively
addressed, depending on the experimental paradigm. We
have performed qualitative analysis of GFAP immunoreactiv-
ity following spinal cord injury (Gomes-Leal et al., 2004),
showing important differences on GFAP immunoreactivity
between gray and white matter in this acute neural disorder.
Sometimes, increased GFAP immunoreactivity is due to a
better exposure of epitopes rather than real increase in
astrocyte number. We have shown a conspicuous decreasein GFAP immunoreactivity (Fig. 5). This dramatic decrease in
GFAP immunoreactivity rendered very difficult to recognize
cell bodies of GFAPþ cells for counting. We believe that in this
case the qualitative analysis is enough to illustrate the
astrocyte alteration.
Further studies, using electron microscopy and double
immunofluorescence for co-labeling cell death and glial as
well as neuronal markers should be performed to confirm
this hypothesis.
The hippocampus is an important neurogenic region in the
adult brain (Aimone et al., 2011). It has been suggested that
the hippocampal adult neurogenesis may contribute to
mechanisms of learning and memory (Aimone et al., 2011;
Koehl and Abrous, 2011; Sahay et al., 2011). There is a
possibility that Al intoxication may impair hippocampal
adult neurogenesis, contributing to learning and memory
deficits. This hypothesis should be investigated in further
studies.4. Experimental procedures
4.1. Experimental animals
Male adult Wistar rats (250–300 g) were obtained from the
Federal University of Para´ Central Animal Facility. All animals
were housed under standard conditions (25 1C, 12 h light–
dark cycle) with food and water available ad libitum. All
experimental procedures were carried out in accordance with
the Principles of Laboratory Animal Care (NIH publication No.
86–23, revised 1985) and European Commission Directive
86/609/EEC for animal experiments under license of the
Ethics Committee on Experimental Animals of the Federal
University of Para´. All possible efforts were made to avoid
animal suffering and distress.4.2. Preparation of aluminum citrate solution
The Al citrate solution was prepared in the Laboratory of
Chemical Analysis from the Geoscience Institute of Federal
University of Para´. In short, 14.23 g of citric acid plus 17.89 g
Al chloride were mixed in deionized water. The solution pH
was adjusted up to 7.0 using ammonia hydroxide. The
solution was stirred under 60 1C for some minutes and a
final volume of 500 mL obtained by adding deionized water.4.3. Al citrate intoxication and experimental groups
Animals were intoxicated with a daily single dose of Al citrate
(320 mg/kg in 1 and 2 mL of deionized water) by gavage
during 4 days. Each animal received 1280 g of Al at the end
of treatment. Control animals received sodium citrate in the
same volume. Experimental animals were perfused 8, 17 and
31 days after the last Al citrate or sodium citrate doses. The
experimental groups are described in Table 1. The intoxica-
tion protocol followed a previous published paper (Kumar,
1998). The chosen survival times allow us to investigate both
behavioral and histological impairment in the first month
after Al intoxication.
Table 1 – Experimental groups, aluminum dose and survival times.
Groups Treatment Dose (mg/kg) N1 of doses Behavioral test time (days) Survival times (days)
1 SC 320 4 1(n¼7) 8(n¼7)
2 AC 320 4 1(n¼7) 8(n¼7)
3 AC 320 4 10(n¼7) 17(n¼7)
4 AC 320 4 24(n¼7) 31(n¼8)
n SC¼Sodium citrate; AC¼Aluminum citrate.
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Behavioral tests were performed in order to evaluate how Al
intoxication influenced both locomotor and learning and
memory performances in the different experimental groups.
They were performed at 24 h after the last dose of Al citrate
or Sodium citrate for animals belonging to G1 and G2 during 3
consecutive days. Animals belonging to G3 and G4 were
submitted to behavioral analysis at 10 and 24 days after the
last Al dose, respectively. The behavioral tests were per-
formed during 3 consecutive days, like previously described
for G1 and G2 animals.
The following behavioral testes were used:
4.5. Open field
In this behavioral test, we followed a protocol published
elsewhere (Bresnahan et al., 1987). This test was used in
order to evaluate possible toxic effects of Al citrate that could
affect locomotor performance of the animals, which could
influence their performance in specific behavioral tests to
address Al-induced learning and memory deficits.
The test was performed in an open field with 606050
cm dimensions and containing 25 square subdivisions of
equal size. Experiments consisted of three trials (5 min each)
in which the animal was removed from its cage and placed at
the center of the open field. The animals’ motor performance
was recorded by a video camera (Sony, USA) and analyzed by
the software Any Maze Stoeltings. The behavioral para-
meters recorded included the number of occurrences of the
exploratory behavior of standing up on the hind legs (rear-
ing), body self-cleaning (grooming), the rat behavior in which
he becomes static for about 10 s (freezing), latency (time
taken to leave the starting point) and distance travelled in
the open field.
4.6. Elevated T-maze
In this test, we followed a previously published protocol,
which is routinely used by our group (Viana et al., 1994; Graeff
et al., 1998). This behavioral test addresses a kind of emo-
tional memory of the animal, related to the environment
imposed by the open arm of the elevated-T maze apparatus,
which is bright and high (Viana et al., 1994; Graeff et al., 1998).
Rodents are aversive to these characteristics and keep a vivid
memory of the aversive situation (time in the open arm)
during the test (Viana et al., 1994; Graeff et al., 1998).
Immediately following the open field test, animals were
maintained at the end of the closed arm with their headsturned toward the maze´s center. The time (latency) used for
the animal to get out from the closed arm was recorded over
300 s (baseline). Further, the first attempt of inhibitory avoid-
ance (IA1) was performed followed by a second IA 30 s later
(IA2). The escape test was performed following the IA 1 and 2
tests. In this test, the time used for the animal to get out from
the open arm was recorded. The tests for memory retention
of IA and escape in the elevated-T maze were performed 72 h
later. At this time, one more IA and escape tests were
performed, as previously described.
4.7. Perfusion and histological analysis
Following the described survival times, animals were deeply
anesthetized with ketamine hydrochloride (72 mg/kg, i.p.)
and xylazine hydrochloride (9 mg/kg, i.p.) and transcardially
perfused with heparinized 0.9% phosphate-buffered saline
(PBS) followed by 4% paraformaldehyde. Surgical manipula-
tion was performed only after both the corneal and the paw
withdraw reflexes were abolished. Brains were post-fixed for
24 h in the same fixative and cryoprotected in different
gradients of sucrose–glycerol solutions over 7 days. The
tissue was then frozen in Tissue Tek, and 30 mm coronal
sections were cut using a cryostat (Carl Zeiss Micron,
Germany). Sections were mounted onto gelatinized slides
and stored in a freezer at 20 1C.
4.8. Immunohistochemistry
To investigate the effect of Al citrate intoxication on hippo-
campal neurons and astrocytes in the different experimental
groups, we performed a series of immunohistochemical
procedures. Mature neuronal bodies (Mullen et al., 1992) were
recognized by the antibody anti-NeuN (1:100, Chemicon-
Millipore, USA). Astrocytosis (Gomes-Leal et al., 2004) was
evaluated by using an antibody anti-GFAP (1:1000, DAKO,
USA). The GFAP immunoreactivity was used to qualitatively
evaluate the effects of Al intoxication on Astrocytes. The
intensity of GFAP immunolabeling and alterations on astro-
cyte morphology were used as the main criteria for addres-
sing astrocyte impairment (Gomes-Leal et al., 2004).
The Immunolabeling protocol used in this study was
detailed elsewhere (Gomes-Leal et al., 2004). Briefly, slide-
mounted sections were removed from the freezer, kept in a
heating oven at 37 1C for 30 min and rinsed once in 0.1 M PBS
for 5 min. To improve labeling intensity, sections were then
pretreated in 0.2 M boric acid (pH 9.0) previously heated to
65 1C for 25 min. This temperature was maintained constant
over the pretreatment period. Sections were further allowed
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agitation in 1% hydrogen peroxide in methanol for 20 min.
Sections were rinsed 3 times (5 min each) in 0.05% PBS/Tween
(Sigma, Saint Louis, MO, USA) and incubated with normal
serum in PBS for 1 h. Without further rinsing, sections were
then incubated with the primary antibody diluted in PBS for
24 h, rinsed in PBS/Tween solution for 5 min (3 times), and
incubated with appropriate secondary antibody for 2 h. As a
negative control, PBS, rather than the primary antibody, was
used. Sections were rinsed again for 5 min (3 times) and
incubated in an avidin – biotin – peroxidase complex (ABC
Kit, Vector Laboratories) for 2 h. Sections were then rinsed 4
times (3 min each rinse) and DAB-reacted according to a
protocol published elsewhere (Gomes-Leal et al., 2004). After
the DAB reaction, sections were rinsed 3 times (3 min each) in
0.1 M phosphate buffer, dehydrated using alcohols and
xylene, and coverslipped. Some sections were also counter-
stained with cresyl violet.4.9. Qualitative analysis
All sections stained with the different histological methods
were surveyed by light microscopy (Olympus BX41). Illustra-
tive images from all experimental groups were obtained
using a digital camera (Olympus Evolt E-330) attached to the
microscope.4.10. Quantitative analysis
We used 3 adjacent coronal sections (per animal) from the
brain of animals belonging to all investigated experimental
group to count the number of neuronal bodies (NeuNþ cells)
per field using a rectangular 0.0750.25 mm grid (objective
40X) in the eyepiece of a microscope. The coronal sections
contained the anterior hippocampus and were located
at 3.60 mm posterior to Bregma (Paxinos et al., 1980).
In the 40X objective, this grid corresponds to an area of
0.01875 mm2. We grid was placed in both CA1 and CA3
hippocampal regions and 3 adjacent fields per (Section 3
sections/animal and 8 animals/survival time) were counted.
Cell bodies were counted in specific grid square, whey they
were more than 50% inside the square. Otherwise, they were
included in the adjacent square. Only clearly immunolabeled
cell bodies were counted, according to the guidelines pub-
lished in our previous investigations (Franco et al., 2012). The
countings were performed blinded to the experimenter.4.11. Statistical analysis
Averages and standard errors were calculated for all counts.
Comparisons between different groups were assessed by
analysis of variance (ANOVA) with Bonferroni post-hoc test
for both histological and behavioral data. In addition, Fried-
man test for repeated measures and Kruskall–Wallis test
were used to confirm the behavioral results. Statistical sig-
nificance was accepted for Po0.05. All statistical analyses
were performed using the BioEstat 5.0 software (Sociedade
Civil Mamiraua´/CNPQ-Brazil).5. Conclusion
In conclusion, acute Al citrate intoxication induces conspic-
uous learning and memory deficits as well as neuronal loss
and decreased GFAP immunoreactivity in the hippocampus
of adult rats. These pathological alterations likely underlie
the behavioral impairment described. Further studies
should investigate the effects of Al intoxication on other glial
cells, for example microglia, as well as the use of anti-
inflammatory and anti-oxidants in order to decrease both
hippocampal damage and behavioral deficits. In addition, the
effect of aging must be investigated, considering that hippo-
campal impairment is present in elderly people with Alzhei-
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